NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,262,829 | +135.4% | 54,526 | +241.1% | 0.28% | +160.6% |
| Q1 2023 | $961,398 | -57.7% | 15,986 | -48.4% | 0.11% | -57.9% |
| Q4 2022 | $2,272,383 | +375.4% | 30,980 | +392.0% | 0.26% | +398.1% |
| Q3 2022 | $478,000 | -78.4% | 6,297 | -80.2% | 0.05% | -76.1% |
| Q2 2022 | $2,212,000 | +90.5% | 31,831 | +105.8% | 0.22% | +73.0% |
| Q4 2021 | $1,161,000 | -38.0% | 15,466 | -4.0% | 0.13% | -11.9% |
| Q3 2021 | $1,872,000 | +38.1% | 16,114 | +163.6% | 0.14% | +19.2% |
| Q2 2021 | $1,356,000 | +108.0% | 6,112 | +23.9% | 0.12% | +110.5% |
| Q1 2021 | $652,000 | – | 4,933 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |